Mckesson Corporation · NYSE:MCK
Mckesson — Non-Deal Roadshow (June 2026)
12 slides from Mckesson's roadshow presentation, Jun 30, 2026
Slide 1: Summer 2026 Roadshow
Summer 2026 Roadshow Shareholder Engagement Program © 2025 McKesson Corporation. All rights reserved. MCKESSON and the MCKESSON logo are registered trademarks of McKesson Corporation in the U.S. and other countries. All other trademarks shown are the property of their respective owners. You may not
Slide 2: Advancing Health Outcomes For All
Advancing Health Outcomes For All STRENGTH IN NORTH AMERICAN DISTRIBUTION Supports With 1/3 of Pharmaceutical Distribution 99% Pharmaceutical Order Accuracy More than SUPERIOR SPECIALTY ASSETS 1.6M • Leading distributor in oncology and specialty therapies PATIENTS are treated • More than 1.6 million
Slide 3: Delivering on Multi-Year Strategic Priorities
Delivering on Multi-Year Strategic Priorities We are focused on accelerating long-term growth and value creation through executing on our four company priorities, which will lead us to our Long-Term Adjusted EPS Growth Target of 13% to 16% Grow Oncology, Strengthen North Modernize & Focus on People
Slide 4: Transforming Our Portfolio to Accelerate Growth
Transforming Our Portfolio to Accelerate Growth Our recently updated reporting structure reflects a strategic evolution of our business – accelerating growth, enhancing transparency, and reinforcing our disciplined approach to capital allocation and shareholder value creation Prior Reporting Structu
Slide 5: Investor Engagement Informed Action in FY 2026
Investor Engagement Informed Action in FY 2026 Our ongoing dialogue with our shareholders informs enhancements to our policies, practices, and disclosures Key Themes Discussed McKesson Actions • Recent appointees bring senior executive leadership and federal health policy experience and supplement t
Slide 6: Highly Experienced and Qualified Board
🗹 Item 1: Election of Directors Highly Experienced and Qualified Board We routinely evaluate the composition of the Board and strategically refresh our membership to ensure we have a balanced mix of expertise across disciplines – 70% of independent directors have a tenure of less than 5 years…
Slide 7: Tailored Board Leadership Structure
🗹 Item 1: Election of Directors Tailored Board Leadership Structure Our Lead Independent Director (LID) exercises substantial authority and provides strong independent leadership and oversight of executive management Lead Independent Director: Dominic Caruso • Acting as liaison between independent…
Slide 8: Governance of AI Matters
Governance of AI Matters We continue to deploy AI and data analytics capabilities to enhance productivity and efficiency and to improve products and services for patients, employees and customers Governing Bodies Ethical Guidelines and Policies Workplace Culture and Talent • Enterprise AI Council se
Slide 9: Executive Compensation Program Aligns Pay and Performance
🗹 Item 3: Advisory Vote on Executive Compensation Executive Compensation Program Aligns Pay and Performance We have developed an executive compensation program designed to strike the right balance of pay for performance, attract and retain an exceptionally talented team, steer our leadership to…
Slide 10: Target Compensation Mix is Primarily Performance-Based
🗹 Item 3: Advisory Vote on Executive Compensation Target Compensation Mix is Primarily Performance-Based Our target direct compensation mix encourages our executives to focus on McKesson’s long-term success and aligns with the long-term interests of our shareholders FY2026 CEO Compensation Mix…
Slide 11: Our Leadership Prescription
Our Leadership Prescription Our Leadership Prescription brings clarity to how we show up — with purpose, speed and heart. A shared framework built for a world moving at digital speed, uniting our I2CARE values and LEADRx behaviors to strengthen how we are Advancing Health Outcomes for All®. 11 McKes
Slide 12: We Request Your Support
We Request Your Support The Board asks that you vote FOR all management proposals at the 2026 Annual Meeting Management Proposals 1 Election of Directors 🗹 FOR 🗹 FOR Ratification of Appointment of Deloitte & Touche as the Company’s Independent Registered 2 Public Accounting Firm 3 Advisory Vote…